Leap Therapeutics Inc. (LPTX) NASDAQ

$2.66 (0.12) (-4.32%)

Market Cap: $71.17M

As of 03/28/24 04:00 PM EDT. Market closed.

(LPTX)

Leap Therapeutics Inc. (LPTX)
NASDAQ

$2.66
(0.12) (-4.32%)

Market Cap: $71.17M

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

leap therapeutics (nasdaq: lptx) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research. for more information about leap therapeutics, visit http://www.leaptx.com or our public filings with the sec that are available via edgar at http://www.sec.gov or via ... read more

leap therapeutics (nasdaq: lptx) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research. for more information about leap therapeutics, visit http://www.leaptx.com or our public filings with the sec that are available via edgar at http://www.sec.gov or via http://www.investors.leaptx.com. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
47 Thorndike St Ste B1-1, Massachusetts, Cambridge, 02141-1799.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
34
Address
47 Thorndike St Ste B1-1, Massachusetts, Cambridge, 02141-1799.
PRICE CHART FOR LEAP THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$2.83
Previous Close
$2.78
Days Range
$2.44 - $2.80
52 week range
$1.24 - $10.20
Volume
192,513
Avg. Volume (30 days)
196,348
Market Cap
$71.17M
Dividend Yield
-
P/E
-
Shares Outstanding
25,600,137
Open
$2.83
Previous Close
$2.78
Days Range
$2.44 - $2.80
52 week range
$1.24 - $10.20
Volume
192,513
Avg. Volume (30 days)
196,348
Market Cap
$71.17M
Dividend Yield
-
P/E
-
Shares Outstanding
25,600,137
FINANCIAL STATEMENTS FOR LEAP THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR LEAP THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
BeiGene, Ltd.10% OwnerSep 24, 2021 Buy$2.852,543,8007,249,8307,348,437Sep 28, 2021, 05:48 PM
PERCEPTIVE ADVISORS LLC10% OwnerJun 22, 2020 Buy$2.001,750,0003,500,0008,476,496Jun 24, 2020, 07:00 PM
ONSI DOUGLAS ECFO, GC, Treasurer & SecretaryFeb 05, 2019 Buy$1.75571,428999,9994,114,804Feb 05, 2019, 04:22 PM
LAWLOR AUGUSTINEChief Operating OfficerFeb 05, 2019 Buy$1.75571,428999,9994,114,804Feb 05, 2019, 04:21 PM
Mirabelli ChristopherCEO, President, ChairmanFeb 05, 2019 Buy$1.75571,428999,9994,114,804Feb 05, 2019, 04:20 PM
HealthCare Ventures IX, L.P.10% OwnerFeb 05, 2019 Buy$1.75571,428999,9994,144,804Feb 05, 2019, 04:19 PM
ONSI DOUGLAS ECFO, GC, Treasurer & SecretaryNov 14, 2017 Buy$6.091,057,7696,436,5243,573,376Nov 16, 2017, 01:45 PM
Mirabelli ChristopherCEO, President, COBNov 14, 2017 Buy$6.091,057,7696,436,5243,573,376Nov 16, 2017, 01:45 PM
HealthCare Ventures IX, L.P.10% OwnerNov 14, 2017 Buy$6.091,057,7696,436,5243,573,376Nov 16, 2017, 01:45 PM
LAWLOR AUGUSTINEChief Operating OfficerNov 14, 2017 Buy$6.091,057,7696,436,5243,573,376Nov 16, 2017, 01:45 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
BeiGene, Ltd.10% Owner09/24/20217,249,830
PERCEPTIVE ADVISORS LLC10% Owner06/22/20203,500,000
ONSI DOUGLAS ECFO, GC, Treasurer & Secretary02/05/2019999,999
LAWLOR AUGUSTINEChief Operating Officer02/05/2019999,999
Mirabelli ChristopherCEO, President, Chairman02/05/2019999,999
HealthCare Ventures IX, L.P.10% Owner02/05/2019999,999
ONSI DOUGLAS ECFO, GC, Treasurer & Secretary11/14/20176,436,524
Mirabelli ChristopherCEO, President, COB11/14/20176,436,524
HealthCare Ventures IX, L.P.10% Owner11/14/20176,436,524
LAWLOR AUGUSTINEChief Operating Officer11/14/20176,436,524
Load More Insider Transactions
FUNDS WITH A POSITION IN LEAP THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BAKER BROS. ADVISORS LP1,172,1750.06%No changeOther
ADAGE CAPITAL PARTNERS GP, L.L.C.942,9180.00809%No changeOther
UBS OCONNOR LLC143,5890.04%-34.56%Value
GEODE CAPITAL MANAGEMENT, LLC203,9600.00009%41.96%Other
BLACKROCK INC.95,1560.00001%112.48%Other
RENAISSANCE TECHNOLOGIES LLC14,4500.00009%NewOther
CHANGE IN SHARES OUTSTANDING FOR LEAP THERAPEUTICS INC
STOCK BUYBACKS FOR LEAP THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2022
80.55%
5Q
12/31/2023
06/30/2022
80.53%
6Q
12/31/2023
03/31/2022
80.53%
7Q

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2022
80.55%
5Q
06/30/2022
80.53%
6Q
03/31/2022
80.53%
7Q
BUYBACK ANNOUNCEMENT(S) FOR LEAP THERAPEUTICS INC
LOADING...